דטרוסיטול 4 מג SR ישראל - עברית - Ministry of Health

דטרוסיטול 4 מג sr

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - קפסולות בשחרור איטי - tolterodine l-tartrate 4 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

דטרוסיטול 2 מג SR ישראל - עברית - Ministry of Health

דטרוסיטול 2 מג sr

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - קפסולות בשחרור איטי - tolterodine l-tartrate 2 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

טוביאז 4 מג ישראל - עברית - Ministry of Health

טוביאז 4 מג

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

טוביאז 8 מג ישראל - עברית - Ministry of Health

טוביאז 8 מג

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

קאברג'קט 20 מקג ישראל - עברית - Ministry of Health

קאברג'קט 20 מקג

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 20 mcg/vial - alprostadil - alprostadil - treatment of erectile dysfunction. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

קאברג'קט 20 מקג ישראל - עברית - Ministry of Health

קאברג'קט 20 מקג

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 20 mcg/vial - alprostadil - alprostadil - treatment of erectile dysfunction. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

קאברג'קט 10 מקג ישראל - עברית - Ministry of Health

קאברג'קט 10 מקג

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 10 mcg - alprostadil - alprostadil - for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed etiology. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

קאברג'קט 10 מקג ישראל - עברית - Ministry of Health

קאברג'קט 10 מקג

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 10 mcg - alprostadil - alprostadil - for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic or mixed etiology. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

גנוטרופין 5.3 מג ישראל - עברית - Ministry of Health

גנוטרופין 5.3 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 5.3 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth weight and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

גנוטרופין 12 מג ישראל - עברית - Ministry of Health

גנוטרופין 12 מג

pfizer pharmaceuticals israel ltd - somatropin - אבקה להכנת תמיסה לזריקה - somatropin 12 mg - somatropin - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.